Literature DB >> 11248718

Smoking cessation in the hospitalized patient using the transtheoretical model of behavior change.

T K Cole.   

Abstract

Tobacco use continues to be the most prevalent cause of preventable morbidity and mortality in the United States, causing more than 430,000 deaths each year, or 1 in every 5 deaths. In addition, many health care providers employed in critical care settings deal with patients who have experienced a near-death event that has led them to consider smoking cessation. The smoking cessation rate 1 year after a myocardial infarction is approximately 70% in those patients who receive a smoking cessation intervention. Theory-based smoking cessation interventions have been found to be effective. The purpose of this article is to present the transtheoretical model as basis for developing a hospital-based smoking cessation intervention. In addition, symptom management options will be discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248718     DOI: 10.1067/mhl.2001.111249

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  4 in total

Review 1.  Interventions for smoking cessation in hospitalised patients.

Authors:  Nancy A Rigotti; Carole Clair; Marcus R Munafò; Lindsay F Stead
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Stages of change, determinants, and mortality for smoking cessation in adult Taiwanese screenees.

Authors:  Dih-Ling Luh; Hsiu-Hsi Chen; Long-Ren Liao; Sam Li-Sheng Chen; Amy Ming-Fang Yen; Ting-Ting Wang; Sherry Yueh-Hsia Chiu; Ching-Yuan Fann
Journal:  Prev Sci       Date:  2015-02

3.  Cigarette smoking: an important renal risk factor - far beyond carcinogenesis.

Authors:  S R Orth
Journal:  Tob Induc Dis       Date:  2002-06-15       Impact factor: 2.600

4.  HIV risk-reduction counseling and testing on behavior change of MSM.

Authors:  Xiping Huan; Weiming Tang; Giridhara R Babu; Jianjun Li; Min Zhang; Xiaoyan Liu; Hongjing Yan; Gengfeng Fu; Jinkou Zhao; Haitao Yang; Roger Detels
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.